The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, has recently introduced the Revamped Pharmaceuticals Technology Upgradation Assistance Scheme (RPTUAS).
About the RPTUAS:
- It aims to elevate the Indian pharmaceutical sector’s technological standards to meet global standards and WHO-GMP norms.
- This scheme is designed to help the pharmaceutical industry comply with the Revised Schedule-M of the Drugs and Cosmetics Rule, 1945, and WHO-GMP standards, thereby enhancing the quality and safety of domestically manufactured pharmaceutical products.
- Originally part of the SPI Scheme, it was known as the PTUAS.
- Key features include broadened eligibility for units with a turnover of less than ₹500 crores, prioritizing MSMEs, offering flexible financing options that move away from traditional credit-linked models and provide subsidies on a reimbursement basis.
- Eligible technological upgradations cover improvements in HVAC, water and steam utilities, waste management, testing laboratories, stability chambers, clean room facilities, and effluent treatment.
- The scheme promises a dynamic incentive structure with incentives based on the average turnover over the past three years, up to a maximum of ₹1.00 crore per unit, ensures enhanced transparency through verification and monitoring by a Project Management Agency, and allows integration with the state government schemes for additional assistance.
- Top of Form

Ref:Source
UPSC IAS Preparation Resources | |
Current Affairs Analysis | Topperspedia |
GS Shots | Simply Explained |
Daily Flash Cards | Daily Quiz |